New antithrombotic strategies for stroke prevention

23 January 2026, 12 am AEDT (Sydney, Melbourne, Canberra, Hobart)
22 January 2026, 11:30 pm ACDT (Adelaide)
22 January 2026, 11 pm AEST (Brisbane)
22 January 2026, 10:30 pm ACST (Darwin)
22 January 2026, 9 pm AWST (Perth)
22 January 2026, 2 pm CET (Central European Time)

Join leading experts as they discuss the latest advances in antithrombotic therapies for stroke prevention, including approaches for embolic stroke of undetermined source and large intracranial atherosclerotic stroke. This interactive session will feature expert presentations followed by a Q&A discussion.

Chair: Prof. Octavio Pontes Neto, Professor, Department of Neurosciences & Behavioral Sciences; Head of Vascular Neurology & Neurological Emergencies, Hospital das Clinicas, Ribeirão Preto – University of São Paulo, Faculdade de Medicina de Ribeirão Preto (FMRP‑USP), Brazil

Moderator: Dr. S Claiborne Johnston, Professor of Neurology & Epidemiology, University of California, San Francisco (UCSF), Director of Stroke Service, UCSF, Chief Medical Officer, Harbor Health, United States

Scientific Program:

Welcome & Introductions
Unmet Needs for Antithrombotic Therapy in Stroke Prevention – Dr. Laetitia Yperzeele, Neurologist, Stroke Unit & NeuroVascular Reference Center, Antwerp University Hospital (UZA), Belgium
Antithrombotics for Prevention of Embolic Stroke of Undetermined Source – Prof. Luciano Sposato, Professor of Neurology, Department of Clinical Neurological Sciences, Western University; Head of the Stroke Program, London Health Sciences Centre (LHSC), Ontario, Canada
Antithrombotics for Prevention of Large Intracranial Atherosclerotic Stroke – Dr. Deidre de Silva, Associate Professor, Duke-NUS Medical School; Consultant Neurologist & Head of Stroke/Cerebrovascular Programme, Singapore General Hospital / National Neuroscience Institute, Singapore
Q&A Discussion
Closing Remarks

This educational activity is supported by an unrestricted educational grant from Bristol-Myers Squibb and Johnson & Johnson.